10x Genomics, Inc. TXG Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$43.54M+76.2% | -$182.63M+28.4% | -$255.1M-53.7% | -$166M-185% | ||
| $36.2M+0.9% | $35.88M+1.0% | $35.51M+40.0% | $25.37M+20.1% | ||
| $109.12M-22.5% | $140.75M-15.7% | $166.95M+22.0% | $136.85M+42.6% | ||
| $136.05M— | —— | —— | —— | ||
| $5.94M-52.1% | $12.39M-74.5% | $48.6M-63.1% | $131.66M+30.0% | ||
| -$13.44M+58.8% | -$32.63M-124% | $137.95M+139% | -$350.89M-229% | ||
| $6.8M-37.7% | $10.91M-20.2% | $13.67M-13.6% | $15.82M-55.2% | ||
| $129.9M+954% | -$15.22M— | —— | -$368.72M-279% | ||
| $130.12M— | —— | —— | -$165.27M-34.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does 10x Genomics, Inc.'s cash flow data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.